Zynx Health launches solution for evidence-based interventions

Zynx Health announced the launch of Lumynz, a surveillance and analytics SaaS platform that measures the utilization of evidence-based interventions and the impact on financial outcomes.

Lumynz provides an interactive, retrospective analysis ofprovider orders utilization against evidence-based interventions to enhanceoutcomes. This analysis highlights how the interventions are being utilized byclinician staff, identifying opportunities to reduce unwarranted care variance.Lumynz enables leaders to engage with clinicians via targeted messages thatguide patient care and improve the clinical decision process. Additionally,Lumynz evaluates if the care provided is accurately reflected in the ChargeDescription Master and on patient claims and identifies charge captureopportunities that have financial impact.

"With Lumynz, hospitals have an interactive solutionthat helps them realize the full value of standardized clinical actions basedon evidence," said Kevin J. Daly, president of Zynx Health. "Over thelast decade, organizations have invested millions to implement CPOE solutionsthat leverage evidence-based protocols, yet few hospitals have reliablesolutions to verify clinicians are actually utilizing these interventions.Lumynz provides hospitals a way to measure adherence with evidence-basedstandards of care, allowing leaders to take appropriate action to ensure thedelivery of the right patient care and more accurate charging.  Furthermore, Lumynz enables hospital leadersto monitor whether initiatives to improve care are actually impacting clinicianbehavior."

Dr. Kelly Philiba, the physician informatics specialist at Zynx Health's innovation partner Health Quest added: "Lumynz enabled us see the complete picture of our evidence-based practices from both clinical and financial perspectives. In March, we implemented a VTE prophylaxis alert but briefly turned it off in May to troubleshoot. Lumynz revealed the initial impact of a 20 percent increase in compliance with this vital intervention, reflected the oscillation with alert deactivation and reactivation, and provided concrete validation that (at minimum) 92 percent of heart failure patients are receiving evidence-based care. It was a retrospective enlightenment for us. Lumynz helps us to visualize these processes, and perhaps more importantly, the data gives us a means to delve into 'why' certain interventions are being employed."